Key facts
- It has raised $2.4M; the latest was Seed Round ($2.2M) in Feb 2026.
- Notable investors include Enterprise Ireland, Lakeside Capital, University College Cork, Boole Investment Syndicate, DeepIE Ventures — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for ArrayPatch
- ·The full record, as it builds
Funding rounds
No funding rounds for ArrayPatch are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ArrayPatch
Developer of microneedle patch technology intended to deliver pain-free, dissolvable drug administration for dermatological and systemic treatments. The company specializes in drug-loaded dissolvable microneedles without polymer carriers, enabling higher drug concentration, improved efficacy, and scalable application across indications such as nail fungal infections, skin cancer, migraines, and peptide therapies, enabling clinicians to enhance patient outcomes and reduce treatment complexity.
- Sector
- Healthcare
- HQ
- Cork, Ireland
- Employees
- 7
- Website
- array-patch.com/
- Ownership
- Privately Held (backing)
ArrayPatch doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ArrayPatch shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ArrayPatch in its N-PORT filings yet. We sweep new filings monthly.